Finnish Institute for Health and Welfare: Hepatitis C is spreading in Finland, particularly through drug use
The Finnish Institute for Health and Welfare (THL) has released new data on hepatitis C infections in Finland. According to the agency, the majority of hepatitis C cases in the country are linked to intravenous drug use. This is a significant public health challenge to which authorities are now paying special attention.
Hepatitis C is an inflammation of the liver that, if left untreated, can lead to serious health problems, such as liver damage. In Finland, infections spread most commonly as a result of the shared use of injection equipment, such as needles and syringes. THL emphasizes that the prevention of infections is of primary importance for safeguarding the health of the population.
Healthcare experts point out that hepatitis C is now highly treatable with medication. However, early detection and access to treatment are key to preventing the further spread of the infection. For this reason, low-threshold health services and counseling are essential methods for reducing infections.
According to THL, improving the situation requires continuous cooperation between social and healthcare services. The goal is to provide sufficient information and support to those who are at the highest risk of contracting the infection. Increasing awareness and preventive measures will continue to be a central part of Finnish health policy.